NF-&kgr;B Activating Scaffold Proteins as Signaling Molecules and Putative Therapeutic Targets

E-ISSN： 1875-533x|10|7|593-602

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.7, 2003-04, pp. : 593-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

Naturally Occurring NF-&kgr;B Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 945-951

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B in Type 1 Diabetes

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 208-217

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of NF-&kgr;B and Proteasome Activity in Tumors: Can We Improve the Therapeutic Potential of Topoisomerase I and Topoisomerase II Poisons

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1945-1958

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr; B and Rheumatic Diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 359-372

Bentham Science Publishers

Access to resources Recommend Favorite